Data / Crowdfunding / Washington / Opticyte, Inc.
Opticyte, Inc.: crowdfunding raise on StartEngine Primary, LLC, $123,999 to $1,234,999 (2025)
Opticyte, Inc., a corporation in Seattle, WA, filed a Form C with the SEC on April 22, 2025 to raise $123,999 to $1,234,999 in common stock through StartEngine Primary, LLC. The offering closed on June 30, 2025. In its most recent fiscal year it reported $0 in revenue and a net loss of $531,002, with 1 employees.
SpecStream is the live web data engine for teams and agents. It reads every Form C on SEC EDGAR each morning, and this page is that reading. Ask for your own cut (a portal, a state, a size, a revenue range) and new raises arrive in your sheet, CRM, Slack or agent as they land.
- Website
- opticyte.com
- Funding portal
- StartEngine Primary, LLC
- Address
- 4000 MASON RD, SUITE 300, Seattle, WA 98195
- Legal form
- Corporation
- Jurisdiction
- DE
- Incorporated
- May 27, 2016
- SEC CIK
- 0001718984
Offering terms
From the amendment filed April 22, 2025.
- Security
- Common Stock
- Price
- $0.33
- Target
- $123,999
- Maximum
- $1,234,999
- Deadline
- June 30, 2025
- Portal compensation
- 7 - 13 percent
Financials
From the Form C-AR filed April 27, 2026.
| Most recent fiscal year | Prior fiscal year | Source | |
|---|---|---|---|
| Revenue | $0 | $0 | sec.gov |
| Cost of goods sold | $0 | $0 | sec.gov |
| Net income | $-531,002 | $-438,291 | sec.gov |
| Taxes paid | $0 | $0 | sec.gov |
| Total assets | $91,346 | $132,478 | sec.gov |
| Cash | $91,346 | $132,478 | sec.gov |
| Accounts receivable | $0 | $0 | sec.gov |
| Short-term debt | $3,214,457 | $0 | sec.gov |
| Long-term debt | $0 | $0 | sec.gov |
Filings
| Filed | Filing | Target | Maximum | Deadline | Note | Source |
|---|---|---|---|---|---|---|
| April 27, 2026 | Annual report | Not listed | Not listed | sec.gov | ||
| July 1, 2025 | Progress update | $123,999 | $1,234,999 | June 30, 2025 | At the close of the offering, the Issuer closed on $234,539.70 and 787,937 shares. | sec.gov |
| April 22, 2025 | Annual report | Not listed | Not listed | sec.gov | ||
| April 22, 2025 | Amendment | $123,999 | $1,234,999 | June 30, 2025 | Issuer is updating their financial statements per the most recent fiscal year and extending their campaign end date to June 30th, 2025. | sec.gov |
| April 4, 2025 | Amendment | $123,999 | $1,234,999 | April 30, 2025 | Issuer is updating their campaign page. | sec.gov |
| February 12, 2025 | Amendment | $123,999 | $1,234,999 | April 30, 2025 | The offering deadline is extended to 04/30/2025. | sec.gov |
| November 25, 2024 | Progress update | $123,999 | $1,234,999 | February 13, 2025 | The issuer has raised over 100% ($134,879.85) of the offering target amount ($123,999.81). | sec.gov |
| November 18, 2024 | Amendment | $123,999 | $1,234,999 | February 13, 2025 | The offering deadline is extended to 02/13/2025. The maximum has increased from $124,000 to $1,235,000. The campaign page includes clearer language, disclaimers on product images and FDA status. Exhibit F adds the Articles of Incorporation and amendments. | sec.gov |
| October 31, 2024 | Offering | $123,999 | $123,999 | January 29, 2025 | sec.gov |
Updated April 27, 2026. Read from SEC EDGAR. Public domain (U.S. government work). Financials are as each company reported them in its Form C, unaudited unless the filing says otherwise. Websites are the ones the companies declared to the SEC. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.